Back to results
US 11,590,076 B2Granted
Cryogel scaffold capable of controlling degree of degradation and soft bio-integrated device in which drug modulating immunosuppressive action in solid microenvironment is loaded in same scaffold
AssigneeResearch & Business Foundation Sungkyunkwan University
InventorsYong Taik Lim, Chanyoung Song, Phuengkham Hathaichanok, Long Ren
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cryogel scaffold capable of controlling the degree of degradation and a soft bio-integrated device in which a drug modulating an immunosuppressive action in solid tumor microenvironment is loaded in the scaffold.
Claims9
A cryogel scaffold comprising a structure in which a first component and a second component are crosslinked,
- wherein the first component is swollen when brought into contact with an aqueous solution, thereby increasing the volume of the scaffold, and the second component is a compound different from the first component, is crosslinkable with the first component and enables the control of degradability by an external stimulus after being crosslinked with the first component, and
- wherein the first component is hyaluronic acid-methacrylate and the second component is hyaluronic acid-aldehyde methacrylate;
- or
- wherein the first component is poly(gamma-glutamic acid)) and the second component is collagen.
1 more element
A soft bio-integrated device comprising:
- a cryogel scaffold comprising a structure in which a first component and a second component are crosslinked;
- and a drug,
- wherein the first component is swollen when brought into contact with an aqueous solution, thereby increasing the volume of the scaffold,
- wherein the second component is a compound different from the first component, is crosslinkable with the first component and enables the control of degradability by an external stimulus after being crosslinked with the first component, and
- wherein the drug is a drug for controlling an immunosuppressive action in a solid tumor microenvironment, and
- wherein the first component is hyaluronic acid-methacrylate and the second component is hyaluronic acid-aldehyde methacrylate;
- or
- wherein the first component is poly(gamma-glutamic acid)) and the second component is collagen.
5 more elements
Dependencies are inferred from the claim text.